Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.
Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check7 days agoChange DetectedAdded Schizophrenia tag and MedlinePlus Genetics related topic, and updated the page revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check14 days agoChange DetectedRevision: v3.3.1 is now displayed on the page, and related topics such as Schizophrenia and MedlinePlus Genetics have been removed from the topics list.SummaryDifference0.2%
- Check21 days agoChange DetectedThe government funding status notice was removed from the page; the study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check36 days agoChange DetectedAdded keywords/MeSH terms 'Schizophrenia' and the related topic 'MedlinePlus Genetics' to the study page; no deletions were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check57 days agoChange DetectedAdded MedlinePlus Genetics topic on schizophrenia to the page. No deletions were found.SummaryDifference0.1%
- Check64 days agoChange DetectedMajor update to page status notice and version; removal of a genetics topic balanced by an explicit operating-status message and version bump.SummaryDifference3%
Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.